文献速递泌尿系结石

摩西2.0激光碎石术的前瞻性随机双盲试验

Prospective randomised double-blind trial: holmium laser lithotripsy with vs without Moses™ 2.0.
PubMed 文献 · BJU Int · 2026-09-13

这项多中心随机双盲试验纳入153例8-20毫米肾结石患者,比较标准激光与摩西2.0激光碎石。结果显示两组手术时间无显著差异(P=0.73),摩西2.0组外科医生工作负荷(NASA-TLX)更低,但结石回推率、并发症率和无石率相当。

要点

  • 摩西2.0未缩短手术时间,但降低外科医生工作负荷。
  • 两组结石回推率、并发症率和无石率无显著差异。
  • 摩西2.0对医生健康有潜在益处。

核心结论

  • 摩西2.0与标准激光碎石相比,手术时间和临床结局无显著差异,但降低外科医生工作负荷。

研究设计与样本

  • 多中心随机双盲临床试验,153例8-20毫米肾结石患者按1:1随机分组,按结石大小分层,患者和外科医生设盲。

主要发现

  • 标准组与摩西2.0组手术时间无显著差异(P=0.73)。
  • 摩西2.0组在努力、挫折感、心理、生理和时间负荷方面评分更低,整体表现评分更高。
  • 视频回顾显示两组结石回推率无差异(P=0.13)。
  • 并发症率(标准组13%;摩西2.0组10%)和无石率(标准组51%;摩西2.0组55%)相当。

关键数值与推荐

  • 主要结局:总手术时间和NASA任务负荷指数(NASA-TLX)评估的外科医生工作负荷。
  • 次要结局:盲法视频评估的结石回推和术后临床结局。

临床怎么用

  • 摩西2.0可用于不增加手术时间的情况下减轻外科医生工作负荷,但需权衡临床结局无差异。

局限性

  • 原文未报告具体局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the effect of Moses™ 2.0 (Lumenis Be Ltd., Yokneam Illit, Israel; Boston Scientific, Marlborough, MA, USA) for lithotripsy of renal stones of 8-20 mm in diameter on operative time, surgeon workload, and retropulsion. SUBJECTS/PATIENTS AND METHODS: In our multicentre, randomised, double-blind clinical trial, patients were randomised 1:1 to standard or Moses 2.0 laser lithotripsy and stratified by stone size. Patients and surgeons were blinded to laser modality. Primary outcomes were total operative time as well as surgeon workload assessed by the National Aeronautics and Space Administration-Task Load Index (NASA-TLX). Secondary outcomes were stone retropulsion evaluated by blinded video review and postoperative clinical outcomes. Linear regression modelling was used for analysis. RESULTS: A total of 153 patients (79 Standard, 74 Moses 2.0) with similar clinical, stone, and operative characteristics were evaluated. There was no significant difference in operative times between the Standard and Moses 2.0 groups (P = 0.73). Moses 2.0 was associated with lower effort, frustration, mental, physical, and temporal workload, as well as higher rated overall performance compared to the standard laser. Video review demonstrated no difference in rates of retropulsion (P = 0.13). Complication rates (Standard: 13%; Moses 2.0: 10%) and stone-free rates (Standard: 51%; Moses: 2.0 55%) were comparable. CONCLUSION: Our study evaluated the impact of Moses 2.0 technology on high-powered renal stone dusting, constituting the largest double-blind trial of its kind to date. There was insufficient evidence to suggest any difference in operative times or clinical outcomes when using Moses 2.0 compared to standard laser lithotripsy. Moses 2.0 was associated with reduced surgeon workload, which has implicit impact on surgeon wellness.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Maciolek KA, Nimmagadda N, Lee AX, et al. Prospective randomised double-blind trial: holmium laser lithotripsy with vs without Moses™ 2.0. BJU Int. 2026. PMID: 42733216. doi:10.1111/bju.70446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。